Clinical trials, a vital aspect of cancer research, can result in new, effective treatments that can help people with cancer live longer, healthier lives. So why is the participation so low?
When a patient asks, "Why me?", Dr. Stephanie Graff considers that they may not be asking for a list of their cancer risk factors.
Immunotherapy—particularly immune checkpoint inhibition—is still experimental. It ends up being quite a difficult discussion for some who had hoped that they could stave off chemotherapy.
On February 3, Dr. Stephanie Graff hopes women in every aspect of medicine will feel inspired to choose themselves, and make their own wellness a priority.
Dr. Evangelia Razis will speak out about cancer and fight against the guilt and shame that attend a cancer diagnosis.
Jason R. Westin, MD